logoTry Persana

Serinus Biosciences - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Serinus Biosciences including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Serinus Biosciences company logo

Disrupting disease at the crossroads

Serinus Biosciences is an AI drug discovery company designing small molecule disrupters for protein-protein interactions (PPI).

HeadquartersNew York, United States
Team size1-10
Founded2022

What is Serinus Biosciences? - Company Overview & Details

Serinus Biosciences is Serinus Biosciences is an AI drug discovery company designing small molecule disrupters for protein-protein interactions (PPI). Founded in 2022, the company is headquartered in New York, United States.

Who Founded Serinus Biosciences?

Serinus Biosciences was founded by Adam Yaari.

Who are the Key Executives at Serinus Biosciences? - Leadership Team

Serinus Biosciences is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Serinus Biosciences

Adam YaariCEO

Chief Technology Officer (CTO) of Serinus Biosciences

CTO

About Adam Yaari - CEO of Serinus Biosciences

Adam Yaari serves as the Chief Executive Officer of Serinus Biosciences, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Serinus Biosciences Company Details & Key Information

Where is Serinus Biosciences located?

Serinus Biosciences is headquartered in New York, United States.

How many employees does Serinus Biosciences have?

Serinus Biosciences has 1-10 employees.

When was Serinus Biosciences founded?

Serinus Biosciences was founded in 2022.

Serinus Biosciences Official Website

How much funding has Serinus Biosciences raised?

Serinus Biosciences has raised $500,000 across 2 funding rounds. The most recent funding was completed on 2022-10-07.

Funding Overview

Serinus Biosciences has secured a total of $500,000 in pre-seed funding to accelerate its research in AI drug discovery.

$500,000
Total Funding Raised
2
Funding Rounds
2022-10-07
Latest Round

Serinus Biosciences Funding History

Pre seed
2022-10-07
$500,000
Series unknown
2022-10-07

Who are the key investors in Serinus Biosciences?

Investor Information Not Available

Detailed information about Serinus Biosciences investors is not currently available in our database.

What are Serinus Biosciences's future plans?

Future Plans Information Not Available

Detailed information about Serinus Biosciences's future plans and strategic initiatives is not currently available in our database.

What are the latest news about Serinus Biosciences?

Serinus Biosciences has 2 recent news updates covering key business developments and market activities.

Serinus Biosciences News Overview

2
Recent Articles
Active
Media Coverage
2023-11-15
Latest Update

What is Serinus Biosciences in the news for?

Serinus Biosciences is currently featured in news for We are thrilled to announce our acceptance and participation in two amazing impact-oriented programs! and other significant business developments.

Recent News Articles About Serinus Biosciences

Article 1
2023-11-15

We are thrilled to announce our acceptance and participation in two amazing impact-oriented programs!

Serinus Biosciences is participating in two impactful programs to boost company growth.

Read News
Article 2
2023-01-17

Want to design new therapeutics to fight cancer? Come work with us!

Serinus Biosciences is hiring to develop advanced AI for drug discovery.

Read News

Serinus Biosciences FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Serinus Biosciences including information about founders, CEO, funding history, investors, headquarters location, and company details. 14 frequently asked questions covering key information about the company.

Serinus Biosciences Questions & Answers - Company Information

Q1

What is Serinus Biosciences?

Serinus Biosciences is an AI drug discovery company designing small molecule disrupters for protein-protein interactions (PPI).

Q2

Who founded Serinus Biosciences?

Serinus Biosciences was founded by Adam Yaari.

Q3

Who is the CEO of Serinus Biosciences?

The CEO of Serinus Biosciences is Adam Yaari. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Serinus Biosciences raised?

Serinus Biosciences has raised a total of $$500,000 across 2 funding rounds. The most recent funding was completed on 2022-10-07.

Q5

Where is Serinus Biosciences headquartered?

Serinus Biosciences is headquartered in New York, United States.

Q6

When was Serinus Biosciences founded?

Serinus Biosciences was founded in 2022.

Q7

How many employees does Serinus Biosciences have?

Serinus Biosciences has 1-10 employees.

Q8

What is Serinus Biosciences's official website?

You can visit Serinus Biosciences's official website at https://www.serinus.bio.

Q9

What was Serinus Biosciences's latest funding round?

Serinus Biosciences's latest funding round was a Pre seed round of $$500,000 completed on 2022-10-07.

Q10

Who is founder?

Adam Yaari

Q11

What does the company do?

Serinus Biosciences is an AI drug discovery company designing small molecule disrupters for protein-protein interactions (PPI).

Q12

How much funding?

$500,000

Q13

Latest funding date?

2022-10-07

Q14

Latest news?

Serinus Biosciences is participating in two impactful programs to boost company growth. Serinus Biosciences is hiring to develop advanced AI for drug discovery.

More Information About Serinus Biosciences

For additional details about Serinus Biosciences, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.